Epic Therapeutics, Inc. has developed a proprietary, protein-matrix drug delivery technology, ProMaxx®, that is produced entirely in water and is substantially more versatile and cost-effective at solving today's pharmaceutical and biotech drug delivery problems than current technologies. In November 2002 Baxter Healthcare Corporation signed a definitive agreement to acquire Epic Therapeutics, Inc.